93 related articles for article (PubMed ID: 27580959)
21. Lymphoproliferative and myeloproliferative disease in Tasmania.
Lickiss JN; Baikie AG; Panton J
Natl Cancer Inst Monogr; 1977 Dec; 47():37-9. PubMed ID: 613244
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of hepatitis C virus infection among patients with lymphoproliferative disorders: a single center survey.
Veneri D; Franchini M; Zanotti R; Frattini F; Randon F; Rinaldi M; Pizzolo G
Am J Hematol; 2007 Nov; 82(11):1031. PubMed ID: 17636475
[No Abstract] [Full Text] [Related]
23. Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study.
Eriksson M; Hållberg B
Cancer Causes Control; 1992 Jan; 3(1):63-7. PubMed ID: 1536915
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and patterns of symptomatic thromboembolism in oncohematology.
Sgarabotto D; Prandoni P; Stefani PM; Scano F; Vianello F; Sartori R; Pietrogrande F; Caenazzo A; Girolami A
Haematologica; 1998 May; 83(5):442-6. PubMed ID: 9658730
[TBL] [Abstract][Full Text] [Related]
25. Association of lymphoid malignancies and Philadelphia-chromosome negative myeloproliferative neoplasms: Clinical characteristics, therapy and outcome.
Masarova L; Newberry KJ; Pierce SA; Estrov Z; Cortes JE; Kantarjian HM; Verstovsek S
Leuk Res; 2015 Aug; 39(8):822-7. PubMed ID: 26012362
[TBL] [Abstract][Full Text] [Related]
26. The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience.
Laurenti L; Tarnani M; Nichele I; Ciolli S; Cortelezzi A; Forconi F; Rossi D; Mauro FR; D'Arena G; Del Poeta G; Montanaro M; Morabito F; Musolino C; Callea V; Falchi L; Tedeschi A; Ambrosetti A; Gaidano G; Leone G; Foà R
Am J Hematol; 2011 Dec; 86(12):1007-12. PubMed ID: 21953617
[TBL] [Abstract][Full Text] [Related]
27. Smoking and philadelphia-negative chronic myeloproliferative neoplasms.
Lindholm Sørensen A; Hasselbalch HC
Eur J Haematol; 2016 Jul; 97(1):63-9. PubMed ID: 26384085
[TBL] [Abstract][Full Text] [Related]
28. Coexistence of lymphoproliferative and myeloproliferative neoplasms with simultaneous CALR and JAK2 V617F mutations.
Yang HS
Cancer Biomark; 2016; 17(4):383-389. PubMed ID: 27662324
[TBL] [Abstract][Full Text] [Related]
29. Lymphoproliferative disorders in individuals with chronic hepatitis B and C in the Turkish population.
Idilman R; Bozkus Y; Seval G; Mizrak D; Cinar K; Ustun Y; Bektas M; Arat M; Akbulut H; Doganay B; Ozden A
J Med Virol; 2011 Jun; 83(6):974-80. PubMed ID: 21503909
[TBL] [Abstract][Full Text] [Related]
30. Chronic hepatitis C virus infection and lymphoproliferative disorders: mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B-cell non-Hodgkin lymphoma.
Caviglia GP; Sciacca C; Abate ML; Olivero A; Rosso C; Touscoz GA; Ciancio A; Rizzetto M; Smedile A
J Gastroenterol Hepatol; 2015 Apr; 30(4):742-7. PubMed ID: 25351042
[TBL] [Abstract][Full Text] [Related]
31. [Establishing a registry of malignant hemopathies in Côte-d'Or. Preliminary results].
Carli PM; Milan C; Lorenzini JL; Devilliers E; Turc C; Cortet P; Bonhomme J
Nouv Rev Fr Hematol (1978); 1983; 25(5):329-35. PubMed ID: 6657484
[TBL] [Abstract][Full Text] [Related]
32. Sequential occurrence of chronic myeloproliferative and lymphoproliferative neoplasms: a collaborative retrospective study by pH-negative MPN latial group.
Breccia M; Petriccione L; Tatarelli C; De Muro M; Trawinska MM; Santopietro M; Spadea A; Di Veroli A; Scalzulli E; Paciaroni K; Tafuri A; Latagliata R; Andriani A; Di Napoli A
Leuk Lymphoma; 2022 Nov; 63(11):2751-2753. PubMed ID: 35758305
[No Abstract] [Full Text] [Related]
33. [Experience of twenty years in modern nomenclature of myeloproliferative and lymphoproliferative diseases].
Werner W
Zentralbl Allg Pathol; 1982; 126(5-6):473-5. PubMed ID: 7158101
[No Abstract] [Full Text] [Related]
34. [Critical states in hemoblastoses (their typical forms and survival in a resuscitation department)].
Vorob'ev AI; Gorelov VG; Gorodetskiĭ VM; Shulutko EM
Ter Arkh; 1993; 65(7):3-6. PubMed ID: 8211775
[No Abstract] [Full Text] [Related]
35. Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms.
Vannucchi AM; Masala G; Antonioli E; Chiara Susini M; Guglielmelli P; Pieri L; Maggi L; Caini S; Palli D; Bogani C; Ponziani V; Pancrazzi A; Annunziato F; Bosi A
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2068-73. PubMed ID: 19531676
[TBL] [Abstract][Full Text] [Related]
36. Acquired von Willebrand syndrome: experience from 2 years in a single laboratory compared with data from the literature and an international registry.
Budde U; Bergmann F; Michiels JJ
Semin Thromb Hemost; 2002 Apr; 28(2):227-38. PubMed ID: 11992245
[TBL] [Abstract][Full Text] [Related]
37. Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience.
Mattar MM; Morad MA; El Husseiny NM; Ali NH; El Demerdash DM
Ann Hematol; 2016 Oct; 95(10):1611-6. PubMed ID: 27468853
[TBL] [Abstract][Full Text] [Related]
38. [Liver cirrhosis and lymphoproliferative diseases: coincidence or association?].
Lombardo L; Rota Scalabrini D; Fracchia M; Torchio B; De La Pierre M
Recenti Prog Med; 1991; 82(7-8):372-7. PubMed ID: 1947400
[TBL] [Abstract][Full Text] [Related]
39. JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasms.
Shirane S; Araki M; Morishita S; Edahiro Y; Takei H; Yoo Y; Choi M; Sunami Y; Hironaka Y; Noguchi M; Koike M; Noda N; Ohsaka A; Komatsu N
Haematologica; 2015 Feb; 100(2):e46-8. PubMed ID: 25398833
[No Abstract] [Full Text] [Related]
40. Incidence of malignancies in heart and/or lung transplant recipients: a single-institution experience.
Roithmaier S; Haydon AM; Loi S; Esmore D; Griffiths A; Bergin P; Williams TJ; Schwarz MA
J Heart Lung Transplant; 2007 Aug; 26(8):845-9. PubMed ID: 17692790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
